4.0 Article

Clinical practice guidelines for children with cancer presenting with fever to the emergency room

Journal

PEDIATRICS INTERNATIONAL
Volume 53, Issue 6, Pages 902-905

Publisher

WILEY
DOI: 10.1111/j.1442-200X.2011.03363.x

Keywords

childhood cancer; clinical practice guidelines; emergency room; febrile neutropenia

Categories

Ask authors/readers for more resources

Background: Patients with febrile neutropenia (FN) may develop severe infection, septic shock, and death. To improve the outcome of pediatric oncology patients with suspected FN, clinical practice guidelines were developed for these patients at the emergency room (ER). The objective of the present study was to evaluate compliance of the clinical practice guidelines for children with cancer presenting with fever to the ER and adverse outcomes after using the guidelines. Methods: A retrospective cohort study was undertaken of children with cancer presenting with fever to the ER from January 2007 to December 2008 after the clinical guidelines were implemented. The control group was the children with cancer who presented with fever during January 2005-December 2006. Guideline compliance was evaluated by recording the time of initial clinical and laboratory assessment and door-to-antibiotic time. The adverse outcomes, including septic shock and death, were determined. Results: There were 170 febrile episodes after using the guidelines. Approximately half (49.4%) of the patients received clinical assessment and laboratory results within 60 min, whereas the antibiotics were administered within 120 min in 80%. Prevalence of septic shock and intensive care unit admission were significantly reduced compared to controls (P = 0.011 and 0.016, respectively). No infection-associated mortality was found after the implementation of the guidelines. Conclusions: Using the clinical practice guidelines for pediatric oncology patients with fever was found to reduce the adverse outcomes and improve survival.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Production and characterization of haploidentical CD19 CAR T cells: Validated to induce a continuous complete remission in a patient with relapsed refractory B-cell ALL

Somsak Prasongtanakij, Usanarat Anurathapan, Thitinee Vanichapol, Bunyada Jittorntrum, Korakot Atjanasuppat, Pongpak Pongpitcha, Samart Pakakasama, Duantida Songdej, Nongnuch Sirachainan, Karan Paisooksantivatana, Suparerk Borwaornpinyo, Borje S. Andersson, Suradej Hongeng

Summary: This study aimed to design and manufacture CD19 CAR-modified T cells for clinical use in Thailand and investigate the impact of different spacer lengths on cytotoxic potential. The results showed that all CD19 CAR T cell constructs exhibited similar levels of cytotoxicity, and the intermediate length spacer construct was selected for clinical application due to its higher transduction efficiency and slower initial proliferation.

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Biochemistry & Molecular Biology

Engineered Zinc Finger Protein Targeting 2LTR Inhibits HIV Integration in Hematopoietic Stem and Progenitor Cell-Derived Macrophages: In Vitro Study

Koollawat Chupradit, Wannisa Khamaikawin, Supachai Sakkhachornphop, Chaniporn Puaninta, Bruce E. Torbett, Suparerk Borwornpinyo, Suradej Hongeng, Methichit Wattanapanitch, Chatchai Tayapiwatana

Summary: The study demonstrates the efficacy and safety of using 2LTRZFP in human CD34(+) HSPCs for gene therapy in HIV-1-infected individuals. The 2LTRZFPmCherry-transduced macrophages showed normal function and phenotype, and exhibited resistance to HIV-1 integration.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Medicine, General & Internal

Betibeglogene Autotemcel Gene Therapy for Non-β0/β0 Genotype β-Thalassemia

Franco Locatelli, Alexis A. Thompson, Janet L. Kwiatkowski, John B. Porter, Adrian J. Thrasher, Suradej Hongeng, Martin G. Sauer, Isabelle Thuret, Ashutosh Lal, Mattia Algeri, Jennifer Schneiderman, Timothy S. Olson, Ben Carpenter, Persis J. Amrolia, Usanarat Anurathapan, Axel Schambach, Christian Chabannon, Manfred Schmidt, Ivan Labik, Heidi Elliot, Ruiting Guo, Mohammed Asmal, Richard A. Colvin, Mark C. Walters

Summary: The study demonstrates that betibeglogene autotemcel therapy can achieve transfusion independence in patients with transfusion-dependent beta-thalassemia, with good safety profile and stable results, suitable for most patients with non-beta(0)/beta(0) genotype.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Pediatrics

Bloodstream bacterial infections in thalassemic pediatric and adolescent patients after hematopoietic stem cell transplantation

Weerapong Chaya, Usanarat Anurathapan, Sasivimol Rattanasiri, Chonnamet Techasaensiri, Samart Pakakasama, Nopporn Apiwattanakul

Summary: Thalassemic patients undergoing HSCT had a lower incidence of IBI compared to patients with other underlying diseases, with catheter-related blood stream infection being the major type of IBI in these patients. Having thalassemia as an underlying disease was the only factor associated with lower IBI in pediatric post-HSCT patients.

PEDIATRIC TRANSPLANTATION (2022)

Article Pharmacology & Pharmacy

Effect of GSTA1 Variants on Busulfan-Based Conditioning Regimen Prior to Allogenic Hematopoietic Stem-Cell Transplantation in Pediatric Asians

Ai-Hoc Nguyen, Mohitosh Biswas, Apichaya Puangpetch, Santirhat Prommas, Samart Pakakasama, Usanarat Anurathapan, Jiratha Rachanakul, Rattanaporn Sukprasong, Nutthan Nuntharadtanaphong, Nutcha Jongjitsook, Suradej Hongeng, Chonlaphat Sukasem

Summary: This study found a significant association between the polymorphism of GSTA1 and variations in the pharmacokinetic properties of busulfan treatment in pediatric Asian patients. Patients carrying the GSTA1*B variant showed a significant impact on the PK of busulfan, with a notable augmentation in AUC.

PHARMACEUTICS (2022)

Article Cell & Tissue Engineering

Single A generation of human induced pluripotent stem cell line (MUi031-A) from a type-3 Gaucher disease patient carrying homozygous mutation on GBA1 gene

Tanapat Pornsukjantra, Kitsada Kangboonruang, Pirut Tong-Ngam, Thipwimol Tim-Aroon, Duangrurdee Wattanasirichaigoon, Usanarat Anurathapan, Suradej Hongeng, Alisa Tubsuwan, Kanit Bhukhai, Nithi Asavapanumas

Summary: In this study, a human induced pluripotent stem cell line for Gaucher disease was established, providing a valuable tool for further investigations.

STEM CELL RESEARCH (2022)

Article Virology

Target Enrichment Metagenomics Reveals Human Pegivirus-1 in Pediatric Hematopoietic Stem Cell Transplantation Recipients

Natali Ludowyke, Worakorn Phumiphanjarphak, Nopporn Apiwattanakul, Suwimon Manopwisedjaroen, Samart Pakakasama, Insee Sensorn, Ekawat Pasomsub, Wasun Chantratita, Suradej Hongeng, Pakorn Aiewsakun, Arunee Thitithanyanont

Summary: In this study, it was found that 21.4% of pediatric patients undergoing hematopoietic stem cell transplant were infected with HPgV-1 virus, with two cases belonging to genotype 2 and one case belonging to genotype 3. The study highlights the importance of screening HSCT patients and donors to reduce the risk of HPgV-1 transmission.

VIRUSES-BASEL (2022)

Article Oncology

Extracellular Vesicle-Based Method for Detecting MYCN Amplification Status of Pediatric Neuroblastoma

Jirawan Panachan, Napat Rojsirikulchai, Nutkridta Pongsakul, Ladawan Khowawisetsut, Pongpak Pongphitcha, Teerapong Siriboonpiputtana, Takol Chareonsirisuthigul, Pitichai Phornsarayuth, Nisakorn Klinkulab, Natini Jinawath, Wararat Chiangjong, Usanarat Anurathapan, Kovit Pattanapanyasat, Suradej Hongeng, Somchai Chutipongtanate

Summary: This study aimed to establish a less invasive method to detect the MYCN status in pediatric neuroblastoma (NB) based on the content of MYCN mRNA in extracellular vesicles (EVs). The study successfully detected MYCN mRNA in microvesicles (MVs) of MYCN-amplified NB cells. The feasibility of the EV-based method was demonstrated using simulated samples and clinical specimens, showing promising results.

CANCERS (2022)

Article Immunology

Ruxolitinib Treatment in an Adolescent With Chronic Graft-Versus-Host Disease Mimicking Eosinophilic Gastrointestinal Disorders: A Case Report

Songpon Getsuwan, Pornthep Tanpowpong, Suradej Hongeng, Usanarat Anurathapan, Samart Pakakasama, Suporn Treepongkaruna

Summary: This article describes a case of an adolescent male who underwent bone marrow transplantation and developed chronic graft-versus-host disease (GVHD) mimicking eosinophilic gastrointestinal disorders (EGIDs). The patient was initially diagnosed with eosinophilic gastroenteritis and received corticosteroids, but later developed recurrent symptoms and persistent hypereosinophilia. Ultimately, the patient was diagnosed with chronic GVHD and treatment with ruxolitinib resulted in significant clinical improvement.

TRANSPLANTATION PROCEEDINGS (2022)

Article Hematology

Effective T-cell replete haploidentical stem cell transplantation for pediatric patients with high-risk hematologic disorders

Supavich Tannumsaeung, Usanarat Anurathapan, Samart Pakakasama, Pongpak Pongpitcha, Duantida Songdej, Nongnuch Sirachainan, Borje S. Andersson, Suradej Hongeng

Summary: This study reviewed the clinical outcomes data of 43 patients undergoing allo-HSCT and compared the effectiveness and tolerability of thiotepa-based and TBI-based conditioning regimens. The results showed no difference in engraftment and overall survival rates between the two regimens.

EUROPEAN JOURNAL OF HAEMATOLOGY (2023)

Review Oncology

Genomics-Driven Precision Medicine in Pediatric Solid Tumors

Praewa Suthapot, Wararat Chiangjong, Parunya Chaiyawat, Pongsakorn Choochuen, Dumnoensun Pruksakorn, Surasak Sangkhathat, Suradej Hongeng, Usanarat Anurathapan, Somchai Chutipongtanate

Summary: Genomic aberrations detection has provided valuable information for precise treatment strategies in cancer. However, the development of pediatric precision oncology is challenging due to limited samples and target genetic aberrations.

CANCERS (2023)

Article Virology

Cytomegalovirus-Specific T Cells in Pediatric Liver Transplant Recipients

Songpon Getsuwan, Nopporn Apiwattanakul, Chatmanee Lertudomphonwanit, Suradej Hongeng, Sophida Boonsathorn, Wiparat Manuyakorn, Pornthep Tanpowpong, Usanarat Anurathapan, Kanchana Tangnararatchakit, Suporn Treepongkaruna

Summary: This study aimed to investigate CMV-specific T cell immune reconstitution among pediatric LT recipients. The results showed that despite intense immunosuppressive therapy, CMV-specific T cell immune reconstitution occurred in pediatric patients post-LT, which could confer protection against CMV reactivation.

VIRUSES-BASEL (2023)

Review Biochemistry & Molecular Biology

Haploidentical Hematopoietic Stem Cell Transplantation in Thalassemia

Usanarat Anurathapan, Samart Pakakasama, Duantida Songdej, Pongpak Pongphitcha, Ampaiwan Chuansumrit, Borje S. Andersson, Suradej Hongeng

Summary: Allogeneic hematopoietic stem cell transplantation (HSCT) is a potentially curative treatment for thalassemia and a program consisting of pharmacologic pre transplant immune suppression phase (PTIS) and other treatment strategies has been shown to improve the success rate of the transplantation in this study.

HEMOGLOBIN (2022)

No Data Available